Breaks Categories: News

MondayMar 22, 2021 11:08 am

NetworkNewsBreaks – Asia Broadband Inc. (AABB) Launches Sales of Gold-Backed Cryptocurrency Token

Asia Broadband (OTC: AABB) announced the sales launch of its AABB Gold (“AABBG”) cryptocurrency token. The token was developed by Core State Holdings Corp. (“CSHC”). The announcement noted that AABB Wallet users who want to purchase the new tokens must update the AABB Wallet app or install the latest version of the app as well as pass the Know Your Client (“KYC”) process. Because the new token will only be available for purchase in exchange for other major cryptocurrencies including Bitcoin, Ethereum and Litecoin, those wanting to purchase AABB Gold token will need to own cryptocurrency in a third-party wallet. To…

Continue Reading

MondayMar 22, 2021 10:57 am

NetworkNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Secures $30.5M in Registered Direct Offering

Uranium Energy (NYSE American: UEC), a Corpus Christi, Texas-based uranium mining and exploration company, has closed its previously announced offering of an aggregate of 10,000,000 shares of common stock of the company. Per an update released today, Uranium Energy secured gross proceeds of $30,500,000 in the registered direct offering, with each of the shares sold at a purchase price of $3.05. The company offered and sold the shares per a securities purchase agreement, dated March 17, 2021, with certain institutional investors. UEC intends to use the net proceeds for additional uranium purchases and for general corporate and working capital purposes.…

Continue Reading

MondayMar 22, 2021 10:47 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Enters Strategic Drug Development Agreement with Catalent Inc. (NYSE: CTLT)

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced its entry into a drug development agreement with Catalent (NYSE: CTLT), the leading global provider of advanced delivery technologies, development and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. According to the update, Cybin will be applying Catalent’s proprietary Zydis(R) orally disintegrating tablet (“ODT”) technology for the delivery of its novel deuterated tryptamine (“CYB003”), a potential therapy for treatment-resistant psychiatric disorders. “We are excited to partner with the team at Catalent with the aim of developing fast-acting, shorter-duration formulations of…

Continue Reading

MondayMar 22, 2021 10:18 am

NetworkNewsBreaks – Grapefruit USA Inc. (GPFT) Announces Increased Bioavailabilty for Flagship THC/CBD-Infused Cream

Grapefruit USA (OTCQB: GPFT), a premiere, fully licensed California-based cannabis company, has reached another technological milestone in the proprietary manufacturing process for its patented, disruptive Hourglass(TM) time-release THC+ cannabinoid delivery cream. In the announcement, the company noted that continued research and analysis of the manufacturing process have led to a substantial reduction in the size of the cream’s THC/CBD-infused particles. The mean particle size now measures 8.2 microns compared to previous samples, which averaged 33.1 and 29.9 microns. The company consistently analyzes the process with the intent of reducing the size of the infused particles, which leads to an increased…

Continue Reading

MondayMar 22, 2021 10:09 am

NetworkNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Completes Enrollment in Phase 2 MS1819-PERT Combination Clinical Trial

AzurRx BioPharma (NASDAQ: AZRX), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (“GI”) diseases, today announced completion of enrollment in its Phase 2 trial evaluating MS1819 in combination with the current standard of care, porcine-derived pancreatic enzyme replacement therapy (“PERT”). The combination trial is for the treatment of severe exocrine pancreatic insufficiency (“EPI”) in patients with cystic fibrosis (“CF”). “We are very pleased to have completed enrollment in our Phase 2 MS1819 plus PERT combination therapy clinical trial,” said James Sapirstein, president, CEO and chairman of AzurRx. “Based on the very encouraging clinical results…

Continue Reading

MondayMar 22, 2021 9:51 am

NetworkNewsBreaks – Knightscope K5 Deployed to Assist in Protection of California Casino

Knightscope, an advanced security technology company that builds fully autonomous security robots that deter, detect and report, has reported that it has completed another new deployment. According to the announcement, the company’s robotics are now at work in Santa Ynez, California, as the newest member of the Chumash Casino security team. A Knightscope K5 will be assisting in the protection of Chumash’s 115,000-square-foot casino, which is part of a AAA four-diamond-rated hotel that offers 320 rooms and 58 suites. “The watchful K5 will patrol the five-story resort parking structure to help keep visitors, staff and their vehicles safe,” the announcement…

Continue Reading

MondayMar 22, 2021 9:24 am

NetworkNewsBreaks – Rritual Superfoods Inc. (CSE: RSF) Provides Update on Manufacturing Run, Plans to Launch Elixirs

Rritual Superfoods (CSE: RSF) (CSE: RSF.WT), a functional superfood company that creates plant-based elixirs that support immunity, focus and relaxation, has announced the successful completion of its second full-scale manufacturing run; the company also announced plans to start its third full-scale manufacturing run early next month. The announcement comes as Rritual provides an update on the anticipated launch of its plant-based superfood elixirs in the United States. In the announcement, the company noted that the second commercial scale manufacturing run was approximately 50% larger than its initial production run. The planned April run is expected to be 200% larger than the current manufacturing run,…

Continue Reading

FridayMar 19, 2021 12:00 pm

NetworkNewsBreaks – Bio-Path Holdings Inc. (NASDAQ: BPTH) Secures $13M in Public Offering

Bio-Path Holdings (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize(R) liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, has closed a public offering of 1,710,600 shares of common stock. Bio-Path Holdings secured approximately $13 million in gross proceeds, with each of the shares sold at the public offering price of $7.60. Bio-Path intends to use the proceeds for working capital and general corporate purposes. ROTH Capital Partners acted as sole placement agent for the offering. For more information about the company, visit www.BioPathHoldings.com About Bio-Path Holdings Inc. Bio-Path Holdings is a biotechnology…

Continue Reading

FridayMar 19, 2021 11:31 am

NetworkNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Commences Trading on the Frankfurt Stock Exchange

Pac Roots (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), an innovative genetics-based cannabis company, today announced that, effective March 18, 2021, it has commenced trading in Europe. According to the update, the company is now listed under the symbol "4XM" on the Frankfurt Stock Exchange. Pac Roots is also quoted on OTC Markets under the symbol "PACRF" and continues to be listed on the Canadian Securities Exchange ("CSE") under the trading symbol "PACR." President and CEO of Pac Roots, Patrick Elliott, said of the milestone, "With the cannabis industry gaining momentum in Europe, this additional listing will help increase our visibility…

Continue Reading

FridayMar 19, 2021 10:37 am

NetworkNewsBreaks – TAAT(TM) Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Offers Alternative that Tastes, Smells and Smokes Like Tobacco

TAAT(TM) (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) today announced the availability of a broadcast titled, “Significant Opportunities in the Global Tobacco Market.” The piece discusses a trend that holds promise for smokers seeking a tobacco-free and nicotine-free smoking experience. The company’s positioning amid this growing demand was highlighted among other market peers transforming everyday items into alternative options by substituting ingredients. Carefully formulated and crafted, these alternatives mimic original flavor, texture, taste and experience while preserving familiarity and enjoyability. This idea is precisely what the company conceived with its TAAT alternative cigarettes. Available in three flavors (Original, Menthol and Smooth),…

Continue Reading